BRIEF published on 07/24/2024 at 12:35, 1 year 4 months ago Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement Merger Financing Nasdaq Biopharmaceutical QTORIN™
BRIEF published on 07/24/2024 at 12:35, 1 year 4 months ago Palvella Therapeutics et Pieris Pharmaceuticals annoncent un accord de fusion définitif Financement Nasdaq Biopharmaceutique Fusionnement QTORIN™
PRESS RELEASE published on 07/24/2024 at 12:30, 1 year 4 months ago Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement Palvella Therapeutics, Inc. and Pieris Pharmaceuticals, Inc. announce a merger to focus on rare genetic skin diseases with QTORIN™ rapamycin. Joint webcast on July 24 at 8:30am ET Merger Clinical-stage Genetic Skin Diseases QTORIN™ Rapamycin FDA-approved Therapies
BRIEF published on 04/19/2024 at 18:15, 1 year 8 months ago Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split Reverse Stock Split Nasdaq Compliance Financial Regulation Pieris Pharmaceuticals Stock Adjustment
BRIEF published on 04/19/2024 at 18:15, 1 year 8 months ago Pieris Pharmaceuticals annonce un regroupement d'actions de 1 pour 80 Réglementation Financière Pieris Pharmaceutique Regroupement D'actions Inversé Conformité NASDAQ Ajustement Des Stocks
PRESS RELEASE published on 04/19/2024 at 18:10, 1 year 8 months ago Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split Pieris Pharmaceuticals, Inc. announces a 1-for-80 reverse stock split effective on April 22, 2024, to comply with Nasdaq listing requirements. No fractional shares will be issued Reverse Stock Split Compliance Nasdaq Pieris Pharmaceuticals Stockholder Ownership
BRIEF published on 03/27/2024 at 13:05, 1 year 8 months ago Pieris Pharmaceuticals Announces New Strategy to Maximize Financial Potential Shareholder Value Pieris Pharmaceuticals Strategic Reorganization Milestone Payments Royalty Potential
BRIEF published on 03/27/2024 at 13:05, 1 year 8 months ago Pieris Pharmaceuticals annonce une nouvelle stratégie pour maximiser le potentiel financier Valeur Pour Les Actionnaires Pieris Pharmaceutique Réorganisation Stratégique Paiements D'étape Potentiel De Redevances
PRESS RELEASE published on 03/27/2024 at 13:00, 1 year 8 months ago Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential Pieris Pharmaceuticals, Inc. announces strategic repositioning to maximize milestone and royalty potential from immuno-oncology assets. Cost-saving measures extend cash runway into 2027 Strategic Repositioning Cost-saving Measures Pieris Pharmaceuticals Milestone Payments Immuno-oncology Assets
Published on 12/22/2025 at 15:00, 5 hours 4 minutes ago World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
Published on 12/22/2025 at 14:40, 5 hours 24 minutes ago Namibia Critical Metals Inc. Receives Proceeds of $1,154,762 from Exercise of Warrants
Published on 12/22/2025 at 14:30, 5 hours 34 minutes ago Prospect Ridge Updates Diamond Drill Program at 100% Owned Camelot Copper-Gold Project in B.C.'S Cariboo Mining District
Published on 12/22/2025 at 14:00, 6 hours 4 minutes ago Rio Grande Resources Completes 2025 Field Program and Advances Drill Targeting at the Winston Gold-Silver Project
Published on 12/22/2025 at 14:00, 6 hours 4 minutes ago PPX Mining Appoints Ernest Mast as President and CEO and Announces Stock Option Grants
Published on 12/22/2025 at 19:31, 33 minutes ago EQS-Adhoc: Marley Spoon Group SE: CEO Daniel Raab Re-appointed and Contract to be Extended until June 2029
Published on 12/22/2025 at 19:00, 1 hour 4 minutes ago PATRIMOINE ET COMMERCE: Déclarations des transactions sur actions propres (hors contrat de liquidité) réalisées le 19 décembre 2025
Published on 12/22/2025 at 18:51, 1 hour 12 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 12/22/2025 at 18:20, 1 hour 44 minutes ago CGTN: How China drives high-quality development through technological innovation
Published on 12/22/2025 at 18:14, 1 hour 49 minutes ago Alzchem Group AG paves the way for continuity and further growth: Management Board contracts of Andreas Niedermaier and Andreas Lösler extended ahead of schedule
Published on 12/22/2025 at 18:33, 1 hour 31 minutes ago ABEO SE RENFORCE ET OBTIENT UNE TRÈS LARGE MAJORITÉ DU CAPITAL DE VOGO AVEC 90,84% DÉTENUS À L’ISSUE DE L’OFFRE RÉOUVERTE
Published on 12/22/2025 at 18:05, 1 hour 59 minutes ago Covivio - Treasury shares transactions between December 15th , 2025 and December 19th, 2025
Published on 12/22/2025 at 18:05, 1 hour 59 minutes ago Covivio - Déclaration des transactions sur actions propres réalisées du 15 décembre au 19 décembre 2025
Published on 12/22/2025 at 17:45, 2 hours 19 minutes ago Déclaration des transactions sur actions propres réalisées du 15 au 19 décembre 2025 dans le cadre du programme de rachat d’actions
Published on 12/22/2025 at 17:35, 2 hours 29 minutes ago DECLARATION HEBDOMADAIRE D'OPERATIONS EFFECTUEES DU 15 AU 19 DECEMBRE 2025
